|
?:authorAffiliation
|
-
[\'Department of Biomedicine and Prevention, Tor Vergata University of Rome, 00133, Rome, Italy. novelli@med.uniroma2.it.\', \'IRCCS Neuromed, Pozzilli, (IS), Italy. novelli@med.uniroma2.it.\', \'Department of Pharmacology, School of Medicine, University of Nevada, Reno, NV, 89557, USA. novelli@med.uniroma2.it.\', \'Department of Pathology, Beth Israel Deaconess Cancer Center, Harvard Medical School, Boston, MA, 02215, USA.\', \'Department of Biology, Tor Vergata University, 00133, Rome, Italy.\', \'Translational Research Unit, Department of Epidemiology and Preclinical Research, National Institute for Infectious Diseases Lazzaro Spallanzani - IRCCS, 00149, Rome, Italy.\', \'Laboratory of Medical Genetics, IRCCS Bambino Gesù Children\'s Hospital, 00165, Rome, Italy.\', \'National Emerging Infectious Diseases Laboratories, Boston University, Boston, MA, USA.\', \'Department of Biomedicine and Prevention, Tor Vergata University of Rome, 00133, Rome, Italy.\', \'St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, Rockefeller University, New York, NY, 10065, USA.\', \'Laboratory of Virology, Department of Epidemiology and Preclinical Research, National Institute for Infectious Diseases Lazzaro Spallanzani - IRCCS, 00149, Rome, Italy.\', \'Department of Experimental Medicine, Tor Vergata University of Rome, 00133, Rome, Italy.\', \'HistoWiz Inc, Brooklyn, NY, 11226, USA.\', \'Department of Microbiology, Icahn school of Medicine at Mount Sinai, New York, NY, 10029, USA.\', \'San Raffaele University of Rome, 00166, Rome, Italy.\', \'Intensive Care Unit, Avicenne Hospital, APHP, Bobigny, France.\', \'INSERM U1272 Hypoxia & Lung, Bobigny, France.\', \'Pneumology Department, Reference Center for Rare Pulmonary Diseases, Hôpital Avicenne, APHP, Bobigny; INSERM UMR1272, Université Paris 13, Bobigny, France.\', \'Hôpital Bichat Claude Bernard, APHP, Paris, France.\', \'Centre d\'investigation Clinique, Inserm CIC, 1425, Paris, France.\', \'Infection, Antimicrobials, Modelling, Evolution (IAME), INSERM, UMRS1137, University of Paris, Paris, France.\', \'AP-HP, Bichat Claude Bernard Hospital, Infectious and Tropical Disease Department, Paris, France.\', \'Laboratory of Clinical Immunology, NIAID, NIH, Bethesda, MD, USA.\', \'Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM, Necker Hospital for Sick Children, Paris, France.\', \'University of Paris, Imagine Institute, Paris, France.\', \'Center for Genomic Medicine, Desert Research Institute, Reno, NV, 89502, USA.\', \'Renown Institute for Cancer, Nevada System of Higher Education, Reno, NV, 89502, USA.\', \'The Donnelly Centre, University of Toronto, Toronto, Ontario, Canada, M5S 3E1 416-946-0863.\', \'Virna Therapeutics, West Roxbury, MA, USA.\', \'Department of Microbiology Boston University, National Emerging Infectious Diseases Laboratories, Boston, MA, 02118, USA.\', \'Howard Hughes Medical Institute, New York, NY, USA.\', \'Department of Pathology, Beth Israel Deaconess Cancer Center, Harvard Medical School, Boston, MA, 02215, USA. pierpaolo.pandolfiderinaldis@renown.org.\', \'Renown Institute for Cancer, Nevada System of Higher Education, Reno, NV, 89502, USA. pierpaolo.pandolfiderinaldis@renown.org.\', \'MBC, Department of Molecular Biotechnology and Health Sciences, University of Turin, Turin, TO, 10126, Italy. pierpaolo.pandolfiderinaldis@renown.org.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}